492 related articles for article (PubMed ID: 15115829)
21. Transcriptional profiling suggests that secondary and primary large B-cell lymphomas of the gastrointestinal (GI) tract are blastic variants of GI marginal zone lymphoma.
Barth TF; Barth CA; Kestler HA; Michl P; Weniger MA; Buchholz M; Möller P; Gress T
J Pathol; 2007 Feb; 211(3):305-13. PubMed ID: 17152084
[TBL] [Abstract][Full Text] [Related]
22. Hidden gene amplifications in aggressive B-cell non-Hodgkin lymphomas detected by microarray-based comparative genomic hybridization.
Wessendorf S; Schwaenen C; Kohlhammer H; Kienle D; Wrobel G; Barth TF; Nessling M; Möller P; Döhner H; Lichter P; Bentz M
Oncogene; 2003 Mar; 22(9):1425-9. PubMed ID: 12618769
[TBL] [Abstract][Full Text] [Related]
23. Gene expression profile towards the prediction of patient survival of gastric cancer.
Xu ZY; Chen JS; Shu YQ
Biomed Pharmacother; 2010 Feb; 64(2):133-9. PubMed ID: 20005068
[TBL] [Abstract][Full Text] [Related]
24. The feasibility of gene expression profiling generated in fine-needle aspiration specimens from patients with follicular lymphoma and diffuse large B-cell lymphoma.
Goy A; Stewart J; Barkoh BA; Remache YK; Katz R; Sneige N; Gilles F
Cancer; 2006 Feb; 108(1):10-20. PubMed ID: 16329118
[TBL] [Abstract][Full Text] [Related]
25. BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma.
Iqbal J; Neppalli VT; Wright G; Dave BJ; Horsman DE; Rosenwald A; Lynch J; Hans CP; Weisenburger DD; Greiner TC; Gascoyne RD; Campo E; Ott G; Müller-Hermelink HK; Delabie J; Jaffe ES; Grogan TM; Connors JM; Vose JM; Armitage JO; Staudt LM; Chan WC
J Clin Oncol; 2006 Feb; 24(6):961-8. PubMed ID: 16418494
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of BACH2 expression in diffuse large B-cell lymphoma: a study of the Osaka Lymphoma Study Group.
Sakane-Ishikawa E; Nakatsuka S; Tomita Y; Fujita S; Nakamichi I; Takakuwa T; Sugiyama H; Fukuhara S; Hino M; Kanamaru A; Soma T; Tsukaguchi M; Igarashi K; Kanakura Y; Aozasa K;
J Clin Oncol; 2005 Nov; 23(31):8012-7. PubMed ID: 16258099
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of Fas (CD95/APO-1) positivity in patients with primary nodal diffuse large B-cell lymphoma.
Eser B; Sari I; Canoz O; Altuntas F; Cakmak E; Ozturk A; Ozkan M; Er O; Cetin M; Unal A
Am J Hematol; 2006 May; 81(5):307-14. PubMed ID: 16628716
[TBL] [Abstract][Full Text] [Related]
28. Molecular outcome prediction in diffuse large-B-cell lymphoma.
Alizadeh AA; Gentles AJ; Lossos IS; Levy R
N Engl J Med; 2009 Jun; 360(26):2794-5. PubMed ID: 19553658
[No Abstract] [Full Text] [Related]
29. Profiling of apoptosis genes identifies distinct types of primary cutaneous large B cell lymphoma.
van Galen JC; Hoefnagel JJ; Vermeer MH; Willemze R; Dijkman R; Tensen CP; de Boer WP; Meijer CJ; Oudejans JJ
J Pathol; 2008 Jul; 215(3):340-6. PubMed ID: 18498125
[TBL] [Abstract][Full Text] [Related]
30. Factors predicting long-term survival in low-risk diffuse large B-cell lymphoma.
Møller MB; Pedersen NT; Christensen BE
Am J Hematol; 2003 Oct; 74(2):94-8. PubMed ID: 14508794
[TBL] [Abstract][Full Text] [Related]
31. Kernel mixture survival models for identifying cancer subtypes, predicting patient's cancer types and survival probabilities.
Ando T; Imoto S; Miyano S
Genome Inform; 2004; 15(2):201-10. PubMed ID: 15706506
[TBL] [Abstract][Full Text] [Related]
32. Interaction between BCL2 and interleukin-10 gene polymorphisms alter outcomes of diffuse large B-cell lymphoma following rituximab plus CHOP chemotherapy.
Park YH; Sohn SK; Kim JG; Lee MH; Song HS; Kim MK; Jung JS; Lee JJ; Kim HJ; Kim DH
Clin Cancer Res; 2009 Mar; 15(6):2107-15. PubMed ID: 19276283
[TBL] [Abstract][Full Text] [Related]
33. Assessment of survival prediction models based on microarray data.
Schumacher M; Binder H; Gerds T
Bioinformatics; 2007 Jul; 23(14):1768-74. PubMed ID: 17485430
[TBL] [Abstract][Full Text] [Related]
34. Molecular profiling of lymphoma.
Akhtar S
N Engl J Med; 2002 Oct; 347(17):1376-7; author reply 1376-7. PubMed ID: 12397201
[No Abstract] [Full Text] [Related]
35. Molecular characteristics of diffuse large-B-cell lymphoma.
Magrath I
N Engl J Med; 2002 Jun; 346(25):1998-9. PubMed ID: 12075062
[No Abstract] [Full Text] [Related]
36. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells.
Dave SS; Wright G; Tan B; Rosenwald A; Gascoyne RD; Chan WC; Fisher RI; Braziel RM; Rimsza LM; Grogan TM; Miller TP; LeBlanc M; Greiner TC; Weisenburger DD; Lynch JC; Vose J; Armitage JO; Smeland EB; Kvaloy S; Holte H; Delabie J; Connors JM; Lansdorp PM; Ouyang Q; Lister TA; Davies AJ; Norton AJ; Muller-Hermelink HK; Ott G; Campo E; Montserrat E; Wilson WH; Jaffe ES; Simon R; Yang L; Powell J; Zhao H; Goldschmidt N; Chiorazzi M; Staudt LM
N Engl J Med; 2004 Nov; 351(21):2159-69. PubMed ID: 15548776
[TBL] [Abstract][Full Text] [Related]
37. Kernel Cox regression models for linking gene expression profiles to censored survival data.
Li H; Luan Y
Pac Symp Biocomput; 2003; ():65-76. PubMed ID: 12603018
[TBL] [Abstract][Full Text] [Related]
38. Gene expression profiles for the prediction of progression-free survival in diffuse large B cell lymphoma: results of a DASL assay.
Kim SJ; Sohn I; Do IG; Jung SH; Ko YH; Yoo HY; Paik S; Kim WS
Ann Hematol; 2014 Mar; 93(3):437-47. PubMed ID: 23975159
[TBL] [Abstract][Full Text] [Related]
39. Clinical quantitation of diagnostic and predictive gene expression levels in follicular and diffuse large B-cell lymphoma by RT-PCR gene expression profiling.
Sakhinia E; Glennie C; Hoyland JA; Menasce LP; Brady G; Miller C; Radford JA; Byers RJ
Blood; 2007 May; 109(9):3922-8. PubMed ID: 17255358
[TBL] [Abstract][Full Text] [Related]
40. Array-based comparative genomic hybridisation analysis reveals recurrent chromosomal alterations in primary diffuse large B cell lymphoma of bone.
Heyning FH; Jansen PM; Hogendoorn PC; Szuhai K
J Clin Pathol; 2010 Dec; 63(12):1095-100. PubMed ID: 20962053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
